nicardipine has been researched along with Coronary Artery Disease in 10 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicardipine proved to be a safe and effective option in the management of complications such as no reflow in patients receiving therapies to restore blood flow following CAD." | 7.01 | Therapeutic and safety outcomes of intracoronary nicardipine in coronary artery disease patients: a systematic review. ( Ahmed, J; Asghar, MS; Hussain, HU; Imran, L; Islam, MS; Javed, SO; Rehan, ST; Salim, A; Sohail, A; Yasmin, F, 2023) |
| "Nicardipine proved to be a safe and effective option in the management of complications such as no reflow in patients receiving therapies to restore blood flow following CAD." | 3.01 | Therapeutic and safety outcomes of intracoronary nicardipine in coronary artery disease patients: a systematic review. ( Ahmed, J; Asghar, MS; Hussain, HU; Imran, L; Islam, MS; Javed, SO; Rehan, ST; Salim, A; Sohail, A; Yasmin, F, 2023) |
| "Angiographic progression of coronary atherosclerosis is frequently observed in clinical practice and is used as an end point in clinical trials; however, its prognostic significance is unclear." | 2.67 | Prognostic significance of progression of coronary atherosclerosis. ( Craven, TE; Lespérance, J; Waters, D, 1993) |
| "or placebo." | 2.67 | Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists? ( Alle, M; Cieslinski, G; Kaltenbach, M; Kober, G; Noack, H; Reifart, N; Roebruck, P; Schneider, W, 1990) |
| "Nicardipine was administered as a 200 μg IC bolus, after which repeat angiography was performed." | 1.51 | The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine. ( Finley, JJ; Fischman, DL; McCarey, M; Mehta, HH; Morris, M; Ruggiero, N; Savage, MP; Walinsky, P, 2019) |
| "Nicardipine therapy was well tolerated without adverse hemodynamic or chronotropic effects." | 1.33 | Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention. ( Awar, M; Fischman, DL; Frankil, C; Huang, RI; Ogilby, JD; Patel, P; Savage, MP; Walinsky, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rehan, ST | 1 |
| Imran, L | 1 |
| Salim, A | 1 |
| Javed, SO | 1 |
| Sohail, A | 1 |
| Hussain, HU | 1 |
| Ahmed, J | 1 |
| Yasmin, F | 1 |
| Islam, MS | 1 |
| Asghar, MS | 1 |
| Jiang, Q | 1 |
| Yang, Y | 1 |
| Sun, H | 1 |
| Tang, Y | 1 |
| Lv, F | 1 |
| Hu, S | 1 |
| Mehta, HH | 1 |
| Morris, M | 1 |
| Fischman, DL | 2 |
| Finley, JJ | 1 |
| Ruggiero, N | 1 |
| Walinsky, P | 2 |
| McCarey, M | 1 |
| Savage, MP | 2 |
| Arora, S | 1 |
| Alfayoumi, F | 1 |
| Khawaja, AT | 1 |
| Dua, A | 1 |
| Srinivasan, V | 1 |
| Gradman, AH | 1 |
| Fischell, T | 1 |
| Haller, S | 1 |
| Ashraf, K | 1 |
| Huang, RI | 1 |
| Patel, P | 1 |
| Ogilby, JD | 1 |
| Awar, M | 1 |
| Frankil, C | 1 |
| Waters, D | 3 |
| Craven, TE | 1 |
| Lespérance, J | 3 |
| Francetich, M | 1 |
| Causey, D | 1 |
| Théroux, P | 2 |
| Chiang, YK | 1 |
| Hudon, G | 2 |
| Lemarbre, L | 2 |
| Reitman, M | 1 |
| Joyal, M | 2 |
| Schneider, W | 1 |
| Kober, G | 1 |
| Roebruck, P | 1 |
| Noack, H | 1 |
| Alle, M | 1 |
| Cieslinski, G | 1 |
| Reifart, N | 1 |
| Kaltenbach, M | 1 |
| Freedman, D | 1 |
| Kamm, B | 1 |
| Dyrda, I | 1 |
| Gosselin, G | 1 |
1 review available for nicardipine and Coronary Artery Disease
| Article | Year |
|---|---|
Therapeutic and safety outcomes of intracoronary nicardipine in coronary artery disease patients: a systematic review.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Circulation; Humans; Nicard | 2023 |
6 trials available for nicardipine and Coronary Artery Disease
| Article | Year |
|---|---|
Stable Hemodynamics within "No-Touch" Saphenous Vein Graft.
Topics: Aged; Beijing; Blood Flow Velocity; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Femal | 2020 |
Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Calcium Channel Blockers; Coronary Artery Disease; Creat | 2009 |
Prognostic significance of progression of coronary atherosclerosis.
Topics: Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; | 1993 |
A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.
Topics: Adult; Aged; Angiography; Calcium Channel Blockers; Cholesterol; Coronary Angiography; Coronary Arte | 1990 |
Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?
Topics: Animals; Coronary Artery Bypass; Coronary Artery Disease; Diet, Atherogenic; Diltiazem; Female; Huma | 1990 |
Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease.
Topics: Adult; Aged; Angiocardiography; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; | 1987 |
3 other studies available for nicardipine and Coronary Artery Disease
| Article | Year |
|---|---|
The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine.
Topics: Adult; Angina Pectoris; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circ | 2019 |
Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervention.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Dis | 2005 |
Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary A | 2006 |